ProVascTec

Cork, Ireland

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

$2.9M raised

Sep 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ProVascTec raised?

ProVascTec has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in September 2025.

Who are ProVascTec's investors?

ProVascTec's investors include Eurostars, Disruptive Technologies Innovation Fund.

Where is ProVascTec headquartered?

ProVascTec is headquartered in Cork, Ireland.

What does ProVascTec do?

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

What stage is ProVascTec at?

ProVascTec is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2025.

MLA

"ProVascTec — Funding & Investors." VCBacked, September 25, 2025, https://www.vcbacked.co/company/provasctec. Accessed July 2, 2026.

APA

VCBacked. (2025). ProVascTec — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/provasctec

Wikipedia (cite web)

{{cite web |title=ProVascTec — Funding & Investors |url=https://www.vcbacked.co/company/provasctec |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2025.